Medicaments of insulin, for retail sale
HS-Code 300431
Supply Chain Analysis
69 entities · 2024 · exports
Source Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
Germany
$2.10B
29.33% share
European Union
$1.94B
27.06% share
France
$1.55B
21.62% share
Few dominant players — high dependency risk.
Share Split
Top Exporting Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 29.33% | $2.10B | -13.34% | -21.07% | 📉 Sustained Drop | |
| 2 | European Union | 27.06% | $1.94B | -25.54% | -44.02% | 📉 Sustained Drop |
| 3 | 21.62% | $1.55B | -21.05% | -29.92% | 📉 Sustained Drop | |
| 4 | 7.21% | $0.52B | +14.83% | +37.85% | 🐢 Slowing | |
| 5 | 2.04% | $0.15B | +16.58% | +79.66% | 🐢 Slowing |
Top Importing Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 15.19% | $0.95B | -20.51% | -28.54% | 📉 Sustained Drop | |
| 2 | 12.31% | $0.77B | +5.55% | +8.06% | 🐢 Slowing | |
| 3 | 6.72% | $0.42B | -47.03% | -81.15% | 📉 Sustained Drop | |
| 4 | 5.81% | $0.36B | -2.28% | +8.10% | ⚠ Momentum Lost | |
| 5 | 3.35% | $0.21B | +55.61% | +58.12% | 🐢 Slowing |
Value vs YoY Growth
Bubble size = market share · Right + Up = high value, high growth
Demand Market Analysis
131 entities · 2024 · imports
Buyer Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
United States
$0.95B
15.19% share
Germany
$0.77B
12.31% share
France
$0.42B
6.72% share
Balanced market — moderate negotiation leverage.
Share Split
Global Trade Map
Exports + Imports by country (hover for details)
Explore more products
Access full trade data across our entire product database.
Have an account? Sign in